HDAC inhibitors induce cell death via diverse mechanisms, such as apoptosis, endoplasmic reticulum (ER) stress, autophagy, and epigenetic modification, and they have recently been suggested to be powerful cancer therapeutic agents8–11. Here, HDAC9 is linked to cancer.